scholarly journals Endoscopic third ventriculostomy for hydrocephalus in infants: A single-center experience

2020 ◽  
Vol 15 (2) ◽  
pp. 302
Author(s):  
Gaurav Jaiswal ◽  
KrishnaGovind Lodha ◽  
TarunKumar Gupta ◽  
Vibhushankar Parashar ◽  
Yogendra Singh
Keyword(s):  
Endoscopic Third Ventriculostomy ◽  
Third Ventriculostomy ◽  
Single Center ◽  
Single Center Experience

scholarly journals Endoscopic Third Ventriculostomy: A Single-Center Experience in Greece

2020 ◽  
Vol 06 (02) ◽  
pp. e71-e76
Author(s):  
V. Kontojannis ◽  
E. Papadopoulos ◽  
J. Ydreos ◽  
D. Isaakidis ◽  
M.M. Gavra ◽  
...  
Keyword(s):  
Endoscopic Third Ventriculostomy ◽  
Third Ventriculostomy ◽  
International Literature ◽  
Single Center ◽  
Ventriculoperitoneal Shunts ◽  
The Past ◽  
Single Center Experience

AbstractEndoscopic third ventriculostomy is an important tool in the treatment of various forms of adult hydrocephalus, and its use is evolving over the past years, proving in many cases more effective than the more traditional ventriculoperitoneal shunts. We present the experience from our department while comparing the results and complications with the international literature.

scholarly journals Endoscopic third ventriculostomy (ETV) for treatment of adult hydrocephalus: long-term followup with 163 patients

2015 ◽  
Vol 42 (S1) ◽  
pp. S41-S41
Author(s):  
A Isaacs ◽  
G Urbaneja ◽  
H Yong ◽  
MG Hamilton
Keyword(s):  
Endoscopic Third Ventriculostomy ◽  
Aqueductal Stenosis ◽  
Primary Treatment ◽  
Term Treatment ◽  
Adult Patients ◽  
Third Ventriculostomy ◽  
Vp Shunt ◽  
Single Center Experience ◽  
Long Term Treatment

Introduction: Treatment of specific patterns of symptomatic hydrocephalus in the adult patient may be accomplished with endoscopic third ventriculostomy (ETV) as an alternative to insertion of a ventriculoperitoneal (VP) shunt. This review examines a single center experience with ETV to treat hydrocephalus in symptomatic adult patients. Methods: Adult patients (≥18 years) with a diagnosis of hydrocephalus who were treated with ETV in Calgary between January 1994 and July 2014 were reviewed using a clinic database and registry. Results: 163 patients were identified (male=92; female=71). Mean age at the time of ETV was 46.5 years (range 18-83.4 years). 118 underwent ETV as a primary treatment and 45 patients underwent treatment after presenting with VP shunt failure (secondary ETV). 113/163 patients had a diagnosis of aqueductal stenosis, 22/163 had a diagnosis of tumor. Mean followup was 8.2 years (range 0.3-18.4 years). Symptoms in 149/163 (91.4%) of ETV patients were better or unchanged at last followup. 104/118 (88.1%) of primary ETV patients were shunt free at last followup. 39/45 (86.7%) of secondary ETV patients were shunt free at last followup. Conclusion: Endoscopic (ETV) treatment is an effective long-term treatment for a select population of adult patients with hydrocephalus.

Sign in / Sign up

Export Citation Format

Share Document